EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanoparticle Targeting Strategies for Lipid and Polymer‐Based Gene Delivery to Immune Cells In Vivo

Manav Jain, Xinjie Yu, Jonathan P Schneck, Jordan J Green iD

Small Science · 30.07.2024

DOI: 10.1002/smsc.202400248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small Science, online erschienen am 30.07.2024. Verfasst von Manav Jain und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering Johns Hopkins University School of Medicine Baltimore MD 21231 USA. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid nanoparticles and polymeric nanoparticles are promising biomaterial platforms for robust intracellular DNA and mRNA delivery, highlighted by the widespread use of nanoparticle‐ (NP) based mRNA vaccines to help end the COVID‐19 pandemic. Recent research has sought to adapt this nanotechnology to transfect and engineer immune cells in vivo. The immune system is an especially appealing target due to its involvement in many different diseases, and ex vivo‐engineered immune cell therapies like chimeric antigen receptor (CAR) T therapy have already demonstrated remarkable clinical success in certain blood cancers. Although gene delivery can potentially address some of the cost and manufacturing concerns associated with current autologous immune cell therapies, transfecting immune cells in vivo is challenging. Not only is extrahepatic NP delivery to lymphoid organs difficult, but immune cells like T cells have demonstrated particular resistance to transfection. Despite these challenges, the modular nature of NPs allows researchers to examine critical structure–function relationships between a particle's properties and its ability to specifically engineer immune cells in vivo. Herein, several nanomaterial components are outlined, including targeting ligands, nucleic acid cargo, chemical properties, physical properties, and the route of administration to specifically target NPs to immune cells for optimal in vivo transfection.

Schlagwörter

Stichwörter der Autor:innen

biomaterialsbiotechnologygene deliveryimmunoengineeringnanotechnology

Autor:innen und Institutionen

  • Department of Biomedical Engineering Johns Hopkins University School of Medicine Baltimore MD 21231 USA.
  • Institute for NanoBioTechnology, and Translational Tissue Engineering Center Johns Hopkins University School of Medicine Baltimore MD 21231 USA.
  • Johns Hopkins Translational ImmunoEngineering Center Johns Hopkins University School of Medicine Baltimore MD 21231 USA.
  • Institute for Cell Engineering Johns Hopkins University School of Medicine Baltimore MD 21231 USA.
  • Department of Chemical & Biomolecular Engineering Johns Hopkins University Baltimore MD 21218 USA.
  • Departments of Pathology and Medicine Johns Hopkins University School of Medicine Baltimore MD 21231 USA.

ORCID-Profile: Jordan J Green

Förderung

  • NIBIB NIH HHS
  • NIH

Zitieren

APA

Jain, M., Yu, X., Schneck, J. P., & Green, J. J. (2024). Nanoparticle Targeting Strategies for Lipid and Polymer‐Based Gene Delivery to Immune Cells In Vivo. Small Science. https://doi.org/10.1002/smsc.202400248

Vancouver

Jain M, Yu X, Schneck JP, Green JJ. Nanoparticle Targeting Strategies for Lipid and Polymer‐Based Gene Delivery to Immune Cells In Vivo. Small Science. 2024. doi:10.1002/smsc.202400248

BibTeX
@article{Jain2024,
  author = {Jain, Manav and Yu, Xinjie and Schneck, Jonathan P and Green, Jordan J},
  title = {Nanoparticle Targeting Strategies for Lipid and Polymer‐Based Gene Delivery to Immune Cells In Vivo},
  journal = {Small Science},
  year = {2024},
  doi = {10.1002/smsc.202400248}
}
Kostenlos starten →